source
- Sarepta's FDA decision date; Flare gets Anna Protopapas as CEOPlus news about Deerfield, InflaRx, Praxis, Nuvectis, Pyxis Oncology, Vistagen, Arcutis Biotherapeutics and Nxera. 🔎 FDA to decide on future of Sarepta exon-skipping drugs by end of February: The…Endpoints · 29d ago↗ source
- Beeline ups its Series A round for immune drug workThe company, which was built by Bain Capital, has now raised more than $426 million in its quest to advance a portfolio of Bristol Myers drugs.BioPharma Dive · 29d ago↗ source
- STAT+: All of Us tests a new approach to collect real-world data for researchThe NIH All of Us Research Program has secured thousands of electronic medical records through an innovative use of patient data-sharing networksSTAT · 29d ago